Thread: NeurologiX: Parkinson`s Disease Phase 2 Trials Ongoing novel gene transfer approach
View Single Post
Old 09-16-2009, 07:59 PM
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
  
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Default NeurologiX: Parkinson`s Disease Phase 2 Trials Ongoing novel gene transfer approach
Parkinson`s Disease Phase 2 Trials Ongoing; Huntington`s Disease Nearing the Clinic

http://www.reuters.com/article/press...009+BW20090914

FORT LEE, N.J.--(Business Wire)--Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will showcase its novel gene transfer approach to Parkinson`s disease and other serious brain and central nervous system diseases at the BioPharm America partnering conference being held in San Francisco, CA on September 17 - 18. John Mordock, Neurologix President and Chief Executive Officer, will discuss the company`s technology, ongoing Phase 2 trial in advanced Parkinson`s disease and other development programs from 4:15 - 4:30 on Thursday September 17 in Salon 14 at the Marriott San Francisco.
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall

I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller
Stitcher is offline   Reply With QuoteReply With Quote